Multiple antibiotic resistance in Stenotrophomonas maltophilia: Involvement of a multidrug efflux system

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 2, 2000, Pages 287-293

  Zhang, L I ^a   Xian Zhi, L I ^a   Poole, Keith ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

6 (1 HYDROXYETHYL) 4 METHYL 7 OXO 3 (5 OXO 3 PYRROLIDINYLTHIO) 1 AZABICYCLO[3.2.0]HEPT 2 ENE 2 CARBOXYLIC ACID; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BACTERIAL PROTEIN; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFPIROME; CHLORAMPHENICOL; CIPROFLOXACIN; CLOXACILLIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; KANAMYCIN; MEROPENEM; NEOMYCIN; NITROCEFIN; NORFLOXACIN; PANIPENEM; PENICILLIN G; PIRAZMONAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STENOTROPHOMONAS MULTIDRUG EFFLUX PROTEIN; STREPTOMYCIN; SULTAMICILLIN; TETRACYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG TRANSPORT; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PUTIDA; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STENOTROPHOMONAS MALTOPHILIA; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BETA-LACTAMS; BIOLOGICAL TRANSPORT; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; HUMANS; MICROBIAL SENSITIVITY TESTS; STENOTROPHOMONAS MALTOPHILIA;

EID: 0343621539     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.2.287-293.2000     Document Type: Article

References (47)

1. Alonso, A., and J. L. Martinez. 1997. Multiple antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 41:1140-1142.
2. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Strahl. 1992. Short protocols in molecular biology, 2nd ed. John Wiley & Sons, Inc., New York, N.Y.
3. Ballestero, S., I. Virseda, H. Escobar, L. Suarez, and F. Baquero. 1995. Stenotrophomonas maltophilia in cystic fibrosis patients. Eur. J. Clin. Microbiol. Infect. Dis. 14:728-729.
4. Burns, J. L., J. Emerson, J. R. Stapp, D. L. Yim, J. Krzewinski, L. Louden, B. W. Ramsey, and C. R. Clausen. 1998. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin. Infect. Dis. 27:158-163.
5. Crowder, M. W., T. R. Walsh, L. Banovic, M. Petit, and J. Spencer. 1998. Overexpression, purification, and characterization of the cloned metallo-β-lactamase L1 from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 42:921-926.
6. Denton, M., N. J. Todd, K. G. Kerr, P. M. Hawkey, and J. M. Littlewood. 1998. Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples. J. Clin. Microbiol. 36:1953-1958.
7. Denton, M., N. J. Todd, and J. M. Littlewood. 1996. Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients. Eur. J. Clin. Microbiol. Infect. Dis. 15:402-405.
8. Felici, A., G. Amicosante, A. Oratore, R. Strom, P. Ledent, B. Joris, L. Fanuel, and J.-M. Frere. 1993. An overview of the kinetic parameters of class B β-lactamases. Biochem. J. 291:151-155.
9. Filip, C., G. Fletcher, J. L. Wulff, and C. F. Earhart. 1973. Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate. J. Bacteriol. 115:717-722.
10. Gotoh, N., H. Tsujimoto, M. Tsuda, K. Okamoto, A. Nomura, T. Wada, M. Nakahashi, and T. Nishino. 1998. Characterization of the MexC-MexD-OprJ multidrug efflux system in ΔmexA-mexB-oprM mutants of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 42:1938-1943.
11. Gutierrez Rodero, F., M. M. Masia, J. Cortes, V. Ortiz de la Tabla, V. Mainar, and A. Vilar. 1996. Endocarditis caused by Stenotrophomonas maltophilia: case report and review. Clin. Infect. Dis. 23:1261-1265.
12. Hoang, T. T., R. R. Karkhoff-Schweizer, A. J. Kutchma, and H. P. Schweizer. 1998. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212:77-86.
13. Kieboom, J., J. J. Dennis, J. A. M. de Bont, and G. J. Zylstra. 1998. Identification and molecular characterization of an efflux pump involved in Pseudomonas putida S12 solvent tolerance. J. Biol. Chem. 273:85-91.
14. Kohler, T., M. Michea-Hamzehpour, U. Henze, N. Gotoh, L. K. Curty, and J.-C. Pechere. 1997. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol. Microbiol. 23:345-354.
15. Krcmery, V., Jr., S. Spanik, I. Krupova, J. Trupl, A. Kunova, M. Smid, and E. Pichnova. 1998. Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case controlled study. J. Chemother. 10:320-325.
16. Lesco Bornet, M., J. Pierre, D. Sarkis Karam, S. Lubera, and E. Bergogne. 1992. Susceptibility of Xanthamonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro. Antimicrob. Agents Chemother. 36:669-571.
17. Li, X.-Z., D. Ma, D. M. Livermore, and H. Nikaido. 1994. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to β-lactam resistance. Antimicrob. Agents Chemother. 38:1742-1752.
18. Li, X.-Z., H. Nikaido, and K. Poole. 1995. Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:1948-1953.
19. Li, X.-Z., L. Zhang, R. Srikumar, and K. Poole. 1998. β-Lactamase inhibitors are substrates of the multidrug efflux pumps of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 42:399-403.
20. Lugtenberg, B., J. Mrijers, R. Peters, P. van der Hoek, and L. van Alphen. 1975. Electrophoretic resolution of the major outer membrane protein of Escherichia coli K12 into four bands. FEBS Lett. 58:254-258.
21. Ma, D., D. N. Cook, M. Alberti, N. G. Pon, H. Nikaido, and J. E. Hearst. 1993. Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J. Bacteriol. 175:6299-6313.
22. Maningo, E., and C. Watanakunakorn. 1995. Xanthamonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units. J. Infect. 31:89-92.
23. Marshall, W. F., M. R. Keating, J. P. Anhalt, and J. M. Steckelberg. 1989. Xanthamonas maltophilia: an emerging nosocomial pathogen. Mayo Clin. Proc. 64:1097-1104.
24. Masuda, N., N. Gotoh, S. Ohya, and T. Nishino. 1996. Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 40:909-913.
25. Matsudaira, P. T. 1989. A practical guide to protein and peptide purification for microsequencing. Academic Press, Inc., San Diego, Calif.
26. Matthew, M., A. M. Harris, M. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J. Gen. Microbiol. 88:169-178.
27. Muder, R. R., A. P. Harris, and S. Muller. 1996. Bacteremia due to Stenotrophomonas (Xanthamonas) maltophilia: a prospective, multicenter study of 91 episodes. Clin. Infect. Dis. 22:508-512.
28. Munter, R. G., A. M. Yinnon, Y. Schlesinger, and C. Hershko. 1998. Infective endocarditis due to Stenotrophomonas (Xanthamonas) maltophilia. Eur. J. Clin. Microbiol. Infect. Dis. 17:353-356.
29. Nikaido, H. 1996. Multidrug efflux pumps of gram-negative bacteria. J. Bacteriol. 178:5853-5859.
30. Nikaido, H., M. Basina, V. Nguyen, and E. Y. Rosenberg. 1998. Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those β-lactam antibiotics containing lipophilic side chains. J. Bacteriol. 180:4686-4692.
31. Papadakis, K. A., S. E. Vartivarian, M. E. Vassilaki, and E. J. Anaissie. 1997. Stenotrophomonas maltophilia meningitis. Report of two cases and review of the literature. J. Neurosurg. 87:106-108.
32. Payne, D. J., R. Cramp, J. H. Batson, J. Neal, and D. Knowles. 1994. Rapid identification of metallo- and serine β-lactamases. Antimicrob. Agents Chemother. 38:991-996.
33. Poole, K., N. Gotoh, H. Tsujimoto, Q. Zhao, A. Wada, T. Yamasaki, S. Neshat, J.-I. Yamagishi, X.-Z. Li, and T. Nishino. 1996. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB multidrug resistant strains of Pseudomonas aeruginosa. Mol. Microbiol. 21:713-724.
34. Poole, K., D. E. Heinrichs, and S. Neshat. 1993. Cloning and sequence analysis of an EnvCD homologue in Pseudomonas aeruginosa: regulation by iron and possible involvement in the secretion of the siderophore pyoverdine. Mol. Microbiol. 10:529-544.
35. Poole, K., K. Krebes, C. McNally, and S. Neshat. 1993. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175:7363-7372.
36. Poole, K., S. Neshat, K. Krebes, and D. E. Heinrichs. 1993. Cloning and nucleotide sequence analysis of the ferripyoverdine receptor gene fpvA of Pseudomonas aeruginosa. J. Bacteriol. 175:4597-4604.
37. Quinn, J. P. 1998. Clinical problems posed by multiresistant nonfermenting gram-negative pathogens. Clin. Infect. Dis. 27:S117-S124.
38. Sanschagrin, F., J. Dufresne, and R. C. Levesque. 1998. Molecular heterogeneity of the L-1 metallo-β-lactamase family from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 42:1245-1248.
39. Simon, R., U. Priefer, and A. Puehler. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram-negative bacteria. Biotechnology 1:784-791.
40. Srikumar, R., T. Kon, N. Gotoh, and K. Poole. 1998. Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain. Antimicrob. Agents Chemother. 42:65-71.
41. Srikumar, R., X.-Z. Li, and K. Poole. 1997. The inner membrane efflux components are responsible for the β-lactam specificity of multidrug efflux pumps in Pseudomonas aeruginosa. J. Bacteriol. 179:7875-7881.
42. Van Couwenberghe, C. J., T. B. Farver, and S. H. Cohen. 1997. Risk factors associated with isolation of Stenotrophomonas (Xanthamonas) maltophilia in clinical specimens. Infect. Control Hosp. Epidemiol. 18:316-321.
43. Vartivarian, S. E., E. Anaissie, G. Bodey, H. Sprigg, and K. Rolston. 1994. A changing pattern of susceptibility of Xanthamonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob. Agents Chemother. 38: 624-627.
44. Vartivarian, S. E., K. A. Papadakis, and E. J. Anaissie. 1996. Stenotrophomonas (Xanthamonas) maltophilia urinary tract infections: a disease that is usually severe and complicated. Arch. Intern. Med. 156:433-435.
45. Vartivarian, S. E., K. A. Papadakis, J. A. Palacios, J. T. Manning, Jr., and E. J. Anaissie. 1994. Mucocutaneous and soft tissue infections caused by Xanthamonas maltophilia. Ann. Intern. Med. 121:969-973.
46. Walsh, T. R., A. P. MacGowan, and P. M. Bennett. 1997. Sequence analysis and enzyme kinetics of the L2 serine β-lactamase from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 41:1460-1464.
47. Zhao, Q., X.-Z. Li, R. Srikumar, and K. Poole. 1998. Contribution of the outer membrane efflux protein OprM to antibiotic resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 42:1682-1688.